To mimic this population of patients and understand the responsiveness of TGFβR2‐mutant tumor cells to TGFβ, we generated two TGFβR2‐deficient pancreatic cancer cell lines Tgfbr2mut1 and Tgfbr2mut2. This evidence concerns the gene TGFBR2 and pancreatic neoplasm.